Search Result

Results for "

PSD

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Amino Acid Derivatives (1) Apoptosis (2) Cyclic GMP-AMP Synthase (1) Drug Derivative (1) HDAC (2) iGluR (17) Indoleamine 2,3-Dioxygenase (IDO) (1) Isotope-Labeled Compounds (7) Liposome (1) mAChR (1) NO Synthase (6) Reactive Oxygen Species (ROS) (1) Reference Standards (2) Small Interfering RNA (siRNA) (7) STING (1) Tau Protein (1)
By Research Areas:	Cardiovascular Disease (1) Inflammation/Immunology (2) Metabolic Disease (2) Neurological Disease (20)
Oligonucleotides:	Rat Pre-designed siRNA Sets (1) Mouse Pre-designed siRNA Sets (1) Human Pre-designed siRNA Sets (5) siRNAs (7)

Inhibitors & Agonists

Peptides

Recombinant Proteins

Isotope-Labeled Compounds

Antibodies

Oligonucleotides

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-P0117

Tat-NR2B9c 5+ Cited Publications Tat-NR2Bct; NA-1	iGluR NO Synthase	Neurological Disease
Tat-NR2B9c (Tat-NR2Bct; NA-1) is a postsynaptic density-95 (PSD-95) inhibitor, with EC₅₀ values of 6.7 nM and 670 nM for PSD-95d2 (PSD-95 PDZ domain 2) and PSD-95d1, respectively. Tat-NR2B9c disrupts the PSD-95/NMDAR interaction, inhibiting NR2A and NR2B binding to PSD-95 with IC₅₀ values of 0.5 μM and 8 μM, respectively. Tat-NR2B9c also inhibits neuronal nitric oxide synthase (nNOS)/PSD-95 interaction, and possesses neuroprotective efficacy .

HY-100456

ZL006 2 Publications Verification	iGluR	Neurological Disease
ZL006 is a potent inhibitor of nNOS/PSD-95 interaction, and inhibits NMDA receptor-mediated NO synthesis.

HY-100457

IC87201 2 Publications Verification	iGluR	Neurological Disease
IC87201, an inhibitor of PSD95-nNOS protein-protein interactions, suppresses NMDAR-dependent NO and cGMP formation.

HY-164288

TDI-6570 TDI-006570	Cyclic GMP-AMP Synthase STING	Neurological Disease Inflammation/Immunology
TDI-6570 (TDI-006570) is a blood-brain barrier-permeable, orally active cGAS inhibitor with an IC₅₀ of 1.64 μM. TDI-6570 exhibits high gastrointestinal absorption and a long brain half-life in mice, and shows no toxicity to primary neurons. By inhibiting the cGAS-STING-IFN signaling pathway, TDI-6570 reduces STING levels and the activation of TBK1, blocks double-stranded DNA-induced cGAS activation and downstream interferon-stimulated gene expression, thereby reducing tau protein spread and improving synaptic loss. TDI-6570 reverses memory deficits, increases the amplitude of long-term potentiation, enhances the MEF2C transcriptional network, restores *PSD-95* and vGAT punctate structures, and significantly improves cognitive resilience. TDI-6570 can be applied to the research of Alzheimer's disease, Parkinson's disease, systemic lupus erythematosus, as well as various central nervous system and autoimmune diseases .

HY-W009118

Fmoc-5-Ava-OH	Amino Acid Derivatives	Others
Fmoc-5-Ava-OH is an amino acid derivative with an Fmoc protecting group, which can be used to synthesize fatty acid-based dimeric peptides with PSD-95 inhibitory activity .

HY-P0117A

Tat-NR2B9c TFA 5+ Cited Publications Tat-NR2Bct TFA; NA-1 TFA	iGluR NO Synthase	Neurological Disease
Tat-NR2B9c TFA (Tat-NR2Bct TFA) is a postsynaptic density-95 (PSD-95) inhibitor, with EC₅₀ values of 6.7 nM and 670 nM for PSD-95d2 (PSD-95 PDZ domain 2) and PSD-95d1, respectively. Tat-NR2B9c TFA disrupts the PSD-95/NMDAR interaction, inhibiting NR2A and NR2B binding to PSD-95 with IC₅₀ values of 0.5 μM and 8 μM, respectively. Tat-NR2B9c TFA also inhibits neuronal nitric oxide synthase (nNOS)/PSD-95 interaction, and possesses neuroprotective efficacy .

HY-117772

FSC231	iGluR	Metabolic Disease Inflammation/Immunology
FSC231 is a PSD‐95/DLG/ZO‐1 (PDZ) domain inhibitor of PICK1. FSC231 has analgesic effects .

HY-P1195

PDZ1 Domain inhibitor peptide	iGluR	Neurological Disease
PDZ1 Domain inhibitor peptide, a cyclic peptide, incorporates a β-Ala lactam side chain linker and targets the PDZ1 domains of the postsynaptic density protein 95 (PSD-95). PDZ1 Domain inhibitor peptide disrupts the GluR6/PSD-95 interaction and is very efficient in competing against the C terminus of GluR6 for the PDZ1 domain .

HY-P11263

AVLX-144	iGluR	Neurological Disease
AVLX-144 is a highly potent inhibitor of postsynaptic density protein 95 (PSD-95). AVLX-144 can be used as a template to develop imaging probes for postsynaptic density (PSD) molecules, and can be labeled with fluorine-18 (¹⁸F) or tritium (³H) to visualize PSD-95 in vivo. AVLX-144 can be utilized for the study of Parkinson's disease .

HY-146885S

16:0-18:1 PS-d31 sodium 1 Publications Verification	Isotope-Labeled Compounds	Others
16:0-18:1 PS-d₃₁ (sodium) is deuterium labeled 16:0-18:1 PS (sodium).

HY-176866

Rodin-A	HDAC	Neurological Disease
Rodin-A is an orally active, brain-penetrant and selective histone deacetylase (HDAC)-co-repressor of repressor element-1 silencing transcription factor (CoREST) complex inhibitor with an IC₅₀ value of 1.80 μM for the CoREST complex, 0.15 μM for HDAC1, and 0.43 μM for HDAC2. Rodin-A increases the acetylation level of histone H3K9, upregulates the expression of neuron-related genes, thereby promoting the increase in dendritic spine density, the colocalization of synaptic proteins (SV2A and PSD95), and the improvement of hippocampal long-term potentiation (LTP), exerting synaptic protection and repair activity. Rodin-A is promising for research of neurodegenerative diseases related to synaptic dysfunction, especially Alzheimer’s disease .

HY-123566

PSD-506 RO 3202904	mAChR	Metabolic Disease
PSD-506 (RO 3202904) is a muscarinic M2/M3 antagonist. PSD-506 has the potential to be used in studies of bladder overactivity and urinary incontinence .

HY-RS24698

Psd Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Psd Rat Pre-designed siRNA Set A contains three designed siRNAs for Psd gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Psd Rat Pre-designed siRNA Set A Psd Rat Pre-designed siRNA Set A

HY-RS11272

PSD Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
PSD Human Pre-designed siRNA Set A contains three designed siRNAs for PSD gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PSD Human Pre-designed siRNA Set A PSD Human Pre-designed siRNA Set A

HY-RS11273

PSD2 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
PSD2 Human Pre-designed siRNA Set A contains three designed siRNAs for PSD2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PSD2 Human Pre-designed siRNA Set A PSD2 Human Pre-designed siRNA Set A

HY-RS11274

PSD3 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
PSD3 Human Pre-designed siRNA Set A contains three designed siRNAs for PSD3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PSD3 Human Pre-designed siRNA Set A PSD3 Human Pre-designed siRNA Set A

HY-RS11275

PSD4 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
PSD4 Human Pre-designed siRNA Set A contains three designed siRNAs for PSD4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PSD4 Human Pre-designed siRNA Set A PSD4 Human Pre-designed siRNA Set A

HY-P2307

Tat-NR2Baa	iGluR NO Synthase	Neurological Disease
Tat-NR2BAA is the control peptide of Tat-NR2B9c (HY-P0117), inactive. The sequence of Tat-NR2BAA is similar to Tat-NR2B9c, but it has a double-point mutation in the COOH terminal tSXV motif, making it incapable of binding PSD-95. Tat-NR2B9c is a membrane-permeant peptide and disrupts PSD-95/NMDAR binding, correlate with uncoupling NR2B- and/or NR2A-type NMDARs from PSD-95 .

HY-P2307A

Tat-NR2Baa TFA	iGluR NO Synthase	Neurological Disease
Tat-NR2BAA TFA is the control peptide of Tat-NR2B9c (HY-P0117), inactive. The sequence of Tat-NR2BAA TFA is similar to Tat-NR2B9c, but it has a double-point mutation in the COOH terminal tSXV motif, making it incapable of binding PSD-95. Tat-NR2B9c is a membrane-permeant peptide and disrupts PSD-95/NMDAR binding, correlate with uncoupling NR2B- and/or NR2A-type NMDARs from PSD-95 .

HY-P1195A

PDZ1 Domain inhibitor peptide TFA	iGluR	Neurological Disease
PDZ1 Domain inhibitor peptide TFA, a cyclic peptide, incorporates a β-Ala lactam side chain linker and targets the PDZ1 domains of the postsynaptic density protein 95 (PSD-95). PDZ1 Domain inhibitor peptide TFA disrupts the GluR6/PSD-95 interaction and is very efficient in competing against the C terminus of GluR6 for the PDZ1 domain .

HY-RS10573

PISD Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
PISD Human Pre-designed siRNA Set A contains three designed siRNAs for PISD gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PISD Human Pre-designed siRNA Set A PISD Human Pre-designed siRNA Set A

HY-P10212

AVLX-125 UCCB01-125	iGluR	Neurological Disease
AVLX-125 (UCCB01-125) is a *PSD-95* and PDZ domain inhibitor with K_d value of 10 nM. AVLX-125 can be used in the study of inflammatory pain .

HY-155355

LY836	iGluR	Neurological Disease
LY836 is an orally active neuroprotective agent. LY836 significantly blocks *PSD95-nNOS* association in cortical neurons. LY836 can be used in study ischemic stroke .

HY-P10401

TAT-GluR6-9c	Apoptosis iGluR	Cardiovascular Disease Neurological Disease
TAT-GluR6-9c is a *GluR6-PSD95* interaction blocker. By regulating the GluR6 mediated signaling pathway, TAT-GluR6-9c inhibits the activation of JNK and phosphorylation of c-Jun, reduces the expression of Fas L and thus reduces the occurrence of apoptosis. TAT-GluR6-9c can be used to study cerebral ischemia and neuroprotective strategies .

HY-143675S

1-Palmitoyl-2-palmitoyl-sn-glycero-3-PS-d9	Isotope-Labeled Compounds	Others
1-Palmitoyl-2-palmitoyl-sn-glycero-3-PS-d₉ is the deuterium labeled 1-Palmitoyl-2-palmitoyl-sn-glycero-3-PS .

HY-167592S

17:0-20:3 PS-d5 1-Heptadecanoyl-2-eicosatrienoyl-sn-glycero(d5)-3-phospho- L-serine sodium	Isotope-Labeled Compounds	Others
17:0-20:3 PS-d₅ (1-Heptadecanoyl-2-eicosatrienoyl-sn-glycero(d₅)-3-phospho- L-serine (sodium)) is deuterium labeled 17:0-20:3 PS .

HY-100458

SCR-4026	NO Synthase	Neurological Disease
SCR-4026 is a neuroprotective agent with blood-brain barrier penetration ability. SCR-4026 exerts neuroprotective effects by disrupting the interaction between neuronal nNOS and *PSD9, with an IC₅₀* of 6.3 μM. SCR-4026 alleviates N-methyl-D-aspartate (NMDA)-induced excitotoxic damage in primary cortical neurons, and also protects neurons in the oxygen-glucose deprivation (OGD) model. SCR-4026 can reduce the cerebral infarct volume in the rat middle cerebral artery occlusion (MCAO) reperfusion model. SCR-4026 can be used for the study of stroke .

HY-175824

PSD-95/nNOS PPI-IN-1	iGluR NO Synthase Apoptosis Reactive Oxygen Species (ROS)	Neurological Disease
PSD-95/nNOS PPI-IN-1 is a inhibitor targeting the *PSD-95/nNOS* interaction with potential blood-brain barrier penetration. PSD-95/nNOS PPI-IN-1 binds to the PSD-95 PDZ2 domain with high affinity (K_i = 19.45 μM). PSD-95/nNOS PPI-IN-1 inhibits glutamate-induced excitotoxicity by reducing intracellular ROS levels and inhibiting apoptosis. PSD-95/nNOS PPI-IN-1 significantly reduces cerebral infarct volume in rat tMCAO models. PSD-95/nNOS PPI-IN-1 can be used for the study of acute ischemic stroke .

HY-176867

Rodin-B	HDAC	Neurological Disease
Rodin-B is a selective histone deacetylase (HDAC)-co-repressor of repressor element-1 silencing transcription factor (CoREST) complex inhibitor with an IC₅₀ value of 0.50 μM for the CoREST complex, 0.27 μM for HDAC1, and 0.28 μM for HDAC2. Rodin-B increases the acetylation level of histone H3K9, upregulates the expression of neuron-related genes, thereby promoting the increase in dendritic spine density, the colocalization of synaptic proteins (SV2A and PSD95), and the improvement of hippocampal long-term potentiation (LTP), exerting synaptic protection and repair activity. Rodin-B is promising for research of neurodegenerative diseases related to synaptic dysfunction, especially Alzheimer’s disease .

HY-RS18221

Psd Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Psd Mouse Pre-designed siRNA Set A contains three designed siRNAs for Psd gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Psd Mouse Pre-designed siRNA Set A Psd Mouse Pre-designed siRNA Set A

HY-100457R

IC87201 (Standard)	iGluR Reference Standards	Neurological Disease
IC87201 (Standard) is the analytical standard of IC87201 (HY-100457). This product is intended for research and analytical applications. IC87201, an inhibitor of PSD95-nNOS protein-protein interactions, suppresses NMDAR-dependent NO and cGMP formation.

HY-178754S

12-Dipalmitoyl-sn-glycero-3-PS-d3 ammonium	Isotope-Labeled Compounds	Others
12-Dipalmitoyl-sn-glycero-3-PS-d₃ ammonium is the deuterium labeled 12-Dipalmitoyl-sn-glycero-3-PS ammonium.

HY-100456R

ZL006 (Standard)	iGluR Reference Standards	Neurological Disease
ZL006 (Standard) is the analytical standard of ZL006 (HY-100456). This product is intended for research and analytical applications. ZL006 is a potent inhibitor of nNOS/PSD-95 interaction, and inhibits NMDA receptor-mediated NO synthesis.

HY-184078

8-F-2-(Me-Pip-Me)-Tryptanthrin	Drug Derivative Indoleamine 2,3-Dioxygenase (IDO) Tau Protein iGluR	Neurological Disease
8-F-2-(Me-Pip-Me)-Tryptanthrin is a tryptanthrin derivative with blood-brain barrier penetration. 8-F-2-(Me-Pip-Me)-Tryptanthrin protects neurons from Aβ-induced apoptosis, inhibits Aβ-induced Tau protein hyperphosphorylation and neuronal synaptic damage, and improves learning and memory abilities in Alzheimer's disease mice. 8-F-2-(Me-Pip-Me)-Tryptanthrin can be used for the research of nervous system diseases, including diseases related to abnormal Tau protein phosphorylation and abnormal *PSD-95* function .

HY-178737S

1,2-Dilinoleoyl-sn-glycero-3-phospho-L-serine-d3 ammonium 18:2 PS-d3 ammonium	Isotope-Labeled Compounds	Others
1,2-Dilinoleoyl-sn-glycero-3-phospho-L-serine-d₃ ammonium (18:2 PS-d₃ ammonium) is the deuterium labeled 1,2-Dilinoleoyl-sn-glycero-3-phospho-L-serine ammonium.

HY-145539SA

1,2-Dipalmitoyl-sn-glycero-3-PS-d62 ammonium	Isotope-Labeled Compounds	Others
1,2-Dipalmitoyl-sn-glycero-3-PS-d₆₂ ammonium is the deuterium labeled 1,2-Dipalmitoyl-sn-glycero-3-PS ammonium. 1,2-Dipalmitoyl-sn-glycero-3-PS is a phosphatidylserine phospholipid. 1,2-Dipalmitoyl-sn-glycero-3-PS is used for the preparation of phospholipid bilayers.

HY-145539S

1,2-Dipalmitoyl-sn-glycero-3-PS-d62 sodium salt	Isotope-Labeled Compounds Liposome	Others
1,2-Dipalmitoyl-sn-glycero-3-PS-d₆₂ sodium is deuterium labeled 1,2-Dipalmitoyl-sn-glycero-3-PS sodium (HY-145539). 1,2-Dipalmitoyl-sn-glycero-3-PS sodium is a phosphatidylserine phospholipid. 1,2-Dipalmitoyl-sn-glycero-3-PS sodium is used for the preparation of phospholipid bilayers .

Cat. No.	Product Name	Target	Research Area

HY-P0117

Tat-NR2B9c 5+ Cited Publications Tat-NR2Bct; NA-1	iGluR NO Synthase	Neurological Disease
Tat-NR2B9c (Tat-NR2Bct; NA-1) is a postsynaptic density-95 (PSD-95) inhibitor, with EC₅₀ values of 6.7 nM and 670 nM for PSD-95d2 (PSD-95 PDZ domain 2) and PSD-95d1, respectively. Tat-NR2B9c disrupts the PSD-95/NMDAR interaction, inhibiting NR2A and NR2B binding to PSD-95 with IC₅₀ values of 0.5 μM and 8 μM, respectively. Tat-NR2B9c also inhibits neuronal nitric oxide synthase (nNOS)/PSD-95 interaction, and possesses neuroprotective efficacy .

HY-W009118

Fmoc-5-Ava-OH	Amino Acid Derivatives	Others
Fmoc-5-Ava-OH is an amino acid derivative with an Fmoc protecting group, which can be used to synthesize fatty acid-based dimeric peptides with PSD-95 inhibitory activity .

HY-P0117A

Tat-NR2B9c TFA 5+ Cited Publications Tat-NR2Bct TFA; NA-1 TFA	iGluR NO Synthase	Neurological Disease
Tat-NR2B9c TFA (Tat-NR2Bct TFA) is a postsynaptic density-95 (PSD-95) inhibitor, with EC₅₀ values of 6.7 nM and 670 nM for PSD-95d2 (PSD-95 PDZ domain 2) and PSD-95d1, respectively. Tat-NR2B9c TFA disrupts the PSD-95/NMDAR interaction, inhibiting NR2A and NR2B binding to PSD-95 with IC₅₀ values of 0.5 μM and 8 μM, respectively. Tat-NR2B9c TFA also inhibits neuronal nitric oxide synthase (nNOS)/PSD-95 interaction, and possesses neuroprotective efficacy .

HY-P1195

PDZ1 Domain inhibitor peptide	iGluR	Neurological Disease
PDZ1 Domain inhibitor peptide, a cyclic peptide, incorporates a β-Ala lactam side chain linker and targets the PDZ1 domains of the postsynaptic density protein 95 (PSD-95). PDZ1 Domain inhibitor peptide disrupts the GluR6/PSD-95 interaction and is very efficient in competing against the C terminus of GluR6 for the PDZ1 domain .

HY-P3983

[Cys(Bzl)84] CD (81-92)	Peptides	Others
[Cys(Bzl)84] CD (81-92) is an acidic peptide. [Cys(Bzl)84] CD (81-92) can be sequencing by negative ion postsource decay (PSD) spectra .

HY-P11263

AVLX-144	iGluR	Neurological Disease
AVLX-144 is a highly potent inhibitor of postsynaptic density protein 95 (PSD-95). AVLX-144 can be used as a template to develop imaging probes for postsynaptic density (PSD) molecules, and can be labeled with fluorine-18 (¹⁸F) or tritium (³H) to visualize PSD-95 in vivo. AVLX-144 can be utilized for the study of Parkinson's disease .

HY-P2307

Tat-NR2Baa	iGluR NO Synthase	Neurological Disease
Tat-NR2BAA is the control peptide of Tat-NR2B9c (HY-P0117), inactive. The sequence of Tat-NR2BAA is similar to Tat-NR2B9c, but it has a double-point mutation in the COOH terminal tSXV motif, making it incapable of binding PSD-95. Tat-NR2B9c is a membrane-permeant peptide and disrupts PSD-95/NMDAR binding, correlate with uncoupling NR2B- and/or NR2A-type NMDARs from PSD-95 .

HY-P2307A

Tat-NR2Baa TFA	iGluR NO Synthase	Neurological Disease
Tat-NR2BAA TFA is the control peptide of Tat-NR2B9c (HY-P0117), inactive. The sequence of Tat-NR2BAA TFA is similar to Tat-NR2B9c, but it has a double-point mutation in the COOH terminal tSXV motif, making it incapable of binding PSD-95. Tat-NR2B9c is a membrane-permeant peptide and disrupts PSD-95/NMDAR binding, correlate with uncoupling NR2B- and/or NR2A-type NMDARs from PSD-95 .

HY-P1195A

PDZ1 Domain inhibitor peptide TFA	iGluR	Neurological Disease
PDZ1 Domain inhibitor peptide TFA, a cyclic peptide, incorporates a β-Ala lactam side chain linker and targets the PDZ1 domains of the postsynaptic density protein 95 (PSD-95). PDZ1 Domain inhibitor peptide TFA disrupts the GluR6/PSD-95 interaction and is very efficient in competing against the C terminus of GluR6 for the PDZ1 domain .

HY-P10212

AVLX-125 UCCB01-125	iGluR	Neurological Disease
AVLX-125 (UCCB01-125) is a *PSD-95* and PDZ domain inhibitor with K_d value of 10 nM. AVLX-125 can be used in the study of inflammatory pain .

HY-P10401

TAT-GluR6-9c	Apoptosis iGluR	Cardiovascular Disease Neurological Disease
TAT-GluR6-9c is a *GluR6-PSD95* interaction blocker. By regulating the GluR6 mediated signaling pathway, TAT-GluR6-9c inhibits the activation of JNK and phosphorylation of c-Jun, reduces the expression of Fas L and thus reduces the occurrence of apoptosis. TAT-GluR6-9c can be used to study cerebral ischemia and neuroprotective strategies .

HY-175824

PSD-95/nNOS PPI-IN-1	iGluR NO Synthase Apoptosis Reactive Oxygen Species (ROS)	Neurological Disease
PSD-95/nNOS PPI-IN-1 is a inhibitor targeting the *PSD-95/nNOS* interaction with potential blood-brain barrier penetration. PSD-95/nNOS PPI-IN-1 binds to the PSD-95 PDZ2 domain with high affinity (K_i = 19.45 μM). PSD-95/nNOS PPI-IN-1 inhibits glutamate-induced excitotoxicity by reducing intracellular ROS levels and inhibiting apoptosis. PSD-95/nNOS PPI-IN-1 significantly reduces cerebral infarct volume in rat tMCAO models. PSD-95/nNOS PPI-IN-1 can be used for the study of acute ischemic stroke .

Species:	Human (2) Rat (1)
Tag:	His (1) Tag Free (1) Avi (1)
Source:	HEK293 (1) E. coli (2)

Cat. No.	Compare	Product Name	Species	Source	Image

HY-P71010

	PSD95 Protein, Rat (His) Disks large homolog 4; Postsynaptic density protein 95; PSD-95; Synapse-associated protein 90; SAP-90; SAP90; PSD95; DLG4	Rat	E. coli
	PSD95 protein plays a crucial role in PDZ domain binding, enzyme binding and signaling receptor binding. It is a structural component of the postsynaptic density and is involved in the regulation of synaptic transmission and cellular organization. PSD95 Protein, Rat (His) is the recombinant rat-derived PSD95 protein, expressed by E. coli , with N-6*His labeled tag.

HY-P703114

	DLG4 Protein, Human (Biotinylated, Avi) PSD95	Human	E. coli
	DLG4 Protein, Human (Biotinylated, Avi) is the recombinant human-derived DLG4, expressed by E. coli , with Avi labeled tag.

HY-P703113

	DLG4 Protein, Human (Biotinylated, HEK293) PSD95	Human	HEK293
	DLG4 Protein, Human (Biotinylated, HEK293) is the recombinant human-derived DLG4, expressed by HEK293 , with tag Free labeled tag.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Product Name	Chemical Structure

HY-146885S

16:0-18:1 PS-d31 sodium 1 Publications Verification
16:0-18:1 PS-d₃₁ (sodium) is deuterium labeled 16:0-18:1 PS (sodium).

HY-143675S

1-Palmitoyl-2-palmitoyl-sn-glycero-3-PS-d9
1-Palmitoyl-2-palmitoyl-sn-glycero-3-PS-d₉ is the deuterium labeled 1-Palmitoyl-2-palmitoyl-sn-glycero-3-PS .

HY-167592S

17:0-20:3 PS-d5
17:0-20:3 PS-d₅ (1-Heptadecanoyl-2-eicosatrienoyl-sn-glycero(d₅)-3-phospho- L-serine (sodium)) is deuterium labeled 17:0-20:3 PS .

HY-178754S

12-Dipalmitoyl-sn-glycero-3-PS-d3 ammonium
12-Dipalmitoyl-sn-glycero-3-PS-d₃ ammonium is the deuterium labeled 12-Dipalmitoyl-sn-glycero-3-PS ammonium.

HY-178737S

1,2-Dilinoleoyl-sn-glycero-3-phospho-L-serine-d3 ammonium
1,2-Dilinoleoyl-sn-glycero-3-phospho-L-serine-d₃ ammonium (18:2 PS-d₃ ammonium) is the deuterium labeled 1,2-Dilinoleoyl-sn-glycero-3-phospho-L-serine ammonium.

HY-145539SA

1,2-Dipalmitoyl-sn-glycero-3-PS-d62 ammonium
1,2-Dipalmitoyl-sn-glycero-3-PS-d₆₂ ammonium is the deuterium labeled 1,2-Dipalmitoyl-sn-glycero-3-PS ammonium. 1,2-Dipalmitoyl-sn-glycero-3-PS is a phosphatidylserine phospholipid. 1,2-Dipalmitoyl-sn-glycero-3-PS is used for the preparation of phospholipid bilayers.

HY-145539S

1,2-Dipalmitoyl-sn-glycero-3-PS-d62 sodium salt
1,2-Dipalmitoyl-sn-glycero-3-PS-d₆₂ sodium is deuterium labeled 1,2-Dipalmitoyl-sn-glycero-3-PS sodium (HY-145539). 1,2-Dipalmitoyl-sn-glycero-3-PS sodium is a phosphatidylserine phospholipid. 1,2-Dipalmitoyl-sn-glycero-3-PS sodium is used for the preparation of phospholipid bilayers .

Host:	Mouse (6) Rabbit (6)
Reactivity:	Human (12) Rat (10) Mouse (10)
Application:	IHC-P (10) ICC/IF (5) IF-Tissue (1) IP (2) WB (8) FC (5) ELISA (6)
Isotype:	IgG (6) IgG1 (4) IgG2b (2)
Conjugation:	Non-conjugated (12) Biotin (2)
Clonality:	polyclonal (1) Monoclonal (7) Recombinant (3)
Modification:	Unmodified (8)

Cat. No.	Compare	Product Name	Application	Reactivity	Image

HY-P84437

	PSD95 Antibody (YA4134) MRD62; PSD95; SAP90; SAP-90	WB, IHC-P, FC, ELISA	Human, Mouse, Rat
	PSD95 Antibody (YA4134) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to PSD95.

HY-P84437A

	PSD95 Antibody (YA4134)(PBS only) MRD62; PSD95; SAP90; SAP-90	WB, IHC-P, FC, ELISA	Human, Mouse, Rat
	PSD95 Antibody (YA4134) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to PSD95.

HY-P80285

	PSD95 Antibody (YA120)	WB, ICC/IF, IHC-P, FC, IP	Human, Mouse, Rat
	PSD95 Antibody (YA120) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to PSD95.

HY-P86390

	PSD95 Antibody (YA6082) DLG4; PSD95; Disks large homolog 4; Postsynaptic density protein 95; PSD-95; Synapse-associated protein 90; SAP-90; SAP90	WB, IHC-P, ICC/IF, IP, ELISA	Human, Mouse, Rat
	PSD95 Antibody (YA6082) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to PSD95.

HY-P810456

	PSD93 Antibody DLG2, Disks large homolog 2, Channel-associated protein of synapse-110, Chapsyn-110, Postsynaptic density protein PSD-93	WB, IHC-P, IF-Tissue, ELISA	Human, Mouse, Rat
	PSD93 Antibody is a Rabbit-derived and non-conjugated IgG polyclonal antibody, targeting to PSD93.

HY-P83442

	PSD93 Antibody (YA3187) DLG2; Disks large homolog 2; Channel-associated protein of synapse-110; Chapsyn-110; Postsynaptic density protein PSD-93	WB, FC	Human, Mouse, Rat
	PSD93 Antibody (YA3187) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to PSD93.

HY-P83442A

	PSD93 Antibody (YA3187)(PBS only) DLG2; Disks large homolog 2; Channel-associated protein of synapse-110; Chapsyn-110; Postsynaptic density protein PSD-93	WB, FC	Human, Mouse, Rat
	PSD93 Antibody (YA3187) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to PSD93.

HY-P88476

	PISD Antibody (YA8160) DJ858B16; dJ858B16.2; PSD; PSDC; PSSC	IHC-P	Human, Mouse, Rat
	PISD Antibody (YA8160) is a Mouse-derived and non-conjugated IgG2b monoclonal antibody, targeting to PISD.

HY-P88476A

	PISD Antibody (YA8160)(PBS only) DJ858B16; dJ858B16.2; PSD; PSDC; PSSC	IHC-P	Human, Mouse, Rat
	PISD Antibody (YA8160) is a Mouse-derived and non-conjugated IgG2b monoclonal antibody, targeting to PISD.

HY-P85363

	SAPAP1 Antibody (YA5055) DLGAP1; DAP1; GKAP; Disks large-associated protein 1; DAP-1; Guanylate kinase-associated protein; hGKAP; PSD-95/SAP90-binding protein 1; SAP90/PSD-95-associated protein 1; SAPAP1	IHC-P, ICC/IF, ELISA	Human
	SAPAP1 Antibody (YA5055) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to SAPAP1.

HY-P85363A

	SAPAP1 Antibody (YA5055)(PBS only) DLGAP1; DAP1; GKAP; Disks large-associated protein 1; DAP-1; Guanylate kinase-associated protein; hGKAP; PSD-95/SAP90-binding protein 1; SAP90/PSD-95-associated protein 1; SAPAP1	IHC-P, ICC/IF, ELISA	Human
	SAPAP1 Antibody (YA5055) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to SAPAP1.

HY-P87016

	PSMD13 Antibody (YA6709) 26S proteasome non ATPase regulatory subunit 13 antibody; 26S proteasome non-ATPase regulatory subunit 13 antibody; 26S proteasome regulatory subunit p40.5 antibody; 26S proteasome regulatory subunit RPN9 antibody; 26S proteasome regulatory subunit S11 antibody; 26S proteasome subunit p40.5 antibody; HSPC027 antibody; P40.5 antibody; Proteasome (prosome, macropain) 26S subunit, non ATPase, 13 antibody; Proteasome 26S subunit, non-ATPase 13 antibody; 26S proteasome non ATPase regulatory subunit 13 antibody; 26S proteasome non-ATPase regulatory subunit 13 antibody; 26S proteasome regulatory subunit p40.5 antibody; 26S proteasome regulatory subunit RPN9 antibody; 26S proteasome regulatory subunit S11 antibody; 26S proteasome subunit p40.5 antibody; HSPC027 antibody; P40.5 antibody; Proteasome (prosome, macropain) 26S subunit, non ATPase, 13 antibody; Proteasome 26S subunit, non-ATPase 13 antibody; PSD13_HUMAN antibody; psmD13 antibody; Rpn9 antibody; S11 antibody;	WB, IHC-P, ICC/IF	Human, Mouse, Rat
	PSMD13 Antibody (YA6709) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to PSMD13.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Host
Reactivity
Application
Dilution Ratio
Molecular Weight
Conjugation
Clonality
Immunogen
Appearance
Isotype
Gene ID
SwissProt ID
Purity
Formulation
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: